The companies will continue with their exclusive agreements, including commercialization of their current portfolio
The tablet donations provided for the treatment of more than 600 million schoolchildren in affected countries in sub-Saharan Africa since 2007
It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
The transaction is anticipated to close in the first quarter of 2022
The acquisition complements and strengthens Merck’s cardiovascular pipeline
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
Domestic market and developing countries will need doses of Indian vaccines
A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report
The healthcare vertical is US-focused, has 35-plus clients and 24,000 employees across 34 locations in five countries
Subscribe To Our Newsletter & Stay Updated
